Should I buy Acadia Healthcare (ACHC) stock or is it too late?
⭐ The most reliable of them, either direction: Guggenheim — 69% of its targets hit on this sector (51 calls tested). It aims for $39 (+29 %), call made on July 31, 2026, maturing on July 31, 2027 (75 d ago).
Firm-by-firm track record on Acadia Healthcare
| Firm | % right | Gain vs sector | Calls | Aims for |
|---|---|---|---|---|
| Raymond James | 70 % | +39.8 % | 10 | $30 -1% |
| B of A Securities | 71 % | +5.7 % | 7 | $13 -57% |
| UBS | 43 % | -0.3 % | 7 | $39 +29% |
| Deutsche Bank | 33 % | -16.2 % | 6 | $20 -34% |
| Keybanc | 40 % | -22.7 % | 5 | $40 +32% |
| RBC Capital | 9 % | -34.3 % | 11 | $31 +3% |
| Barclays | 12 % | -51.2 % | 8 | $32 +6% |
| BMO Capital | 67 % | +36.6 % | 6 | — |
✅ Reasons to believe
- 67% of analysts rate it a buy (Buy consensus, 9 ratings) — a sign of market conviction.
- Median price target $33, i.e. +9% from the current price ($30).
⚠️ Reasons to hesitate
- Even the most reliable firm on ACHC, Jefferies (75% hit rate, 4 scored calls), only targets $30 (call made on June 3, 2026, maturing on June 3, 2027) (-1%) in its most recent call, and $15 (call made on January 22, 2026, maturing on January 22, 2027) (-50%) in the one coming due soonest. The stock may already have run past its target.
- The consensus is not unanimous: of 9 ratings, 3 are neutral.
- A 12-month target is not a guaranteed path: the price can fall in the meantime.
- No dividend: your return depends only on price appreciation.
The analyst consensus on ACHC
Median target $33 (+9%) · 9 ratings · Buy consensus
⚠️ Information, not investment advice. Past performance does not guarantee future results. Analyst targets on a ~12-month horizon.
Frequently asked questions
Should you invest in Acadia Healthcare now?
We won't decide for you. The facts: 67% of analysts rate it a buy, median target $33 (+9%), and Jefferies (most reliable on ACHC, 75%) targets $30. Weigh that against valuation. This is not personalized advice.
Is it too late to invest in Acadia Healthcare?
Not according to analysts: the median target ($33) is still +9% above the current price ($30) (most reliable on ACHC: Jefferies, 75%). The real question isn't "too late" but the price-to-value gap and risk. Not advice.
Is Acadia Healthcare still worth investing in?
It depends on the gap between the price ($30) and its estimated value: analysts target $33 on median (+9%), with 67% buys (most reliable on ACHC: Jefferies, 75%). Cross-check with their real reliability on ACHC and the cautions above. Information, not advice.
What's the main risk in buying ACHC?
Even the most reliable firm on ACHC, Jefferies (75% hit rate, 4 scored calls), only targets $30 (call made on June 3, 2026, maturing on June 3, 2027) (-1%) in its most recent call, and $15 (call made on January 22, 2026, maturing on January 22, 2027) (-50%) in the one coming due soonest. The stock may already have run past its target.
→ Go deeper: the full Acadia Healthcare profile (consensus, analyst reliability, price target, performance).